Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
skin cancer
Pharma
Checkpoint passes FDA checkpoint for PD-L1 drug Unloxcyt
While Unloxcyt is the first PD-L1 inhibitor for CSCC, Regeneron’s Libtayo and Merck’s Keytruda are already available in the indication.
Angus Liu
Dec 16, 2024 10:59am
Castle Biosciences taps ‘Real Housewife’ for melanoma awareness
Jul 23, 2024 12:23pm
Almirall urges sun-chasers to 'Stay Vigilant' in new AK campaign
May 30, 2024 11:37am
Castle Biosciences gets on board the Sun Bus for another year
May 30, 2023 10:15am
74% of consumers haven't had a skin exam in past year: DermTech
May 4, 2023 9:15am
DermTech builds skin cancer push upon millennial, Gen X regrets
Apr 6, 2023 7:25am
